Is a complete BCBA/PFE research report available?

No complete published report is available for bcba/PFE (BCBA/PFE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/PFE (BCBA/PFE)

Buenos Aires Stock Exchange: BCBA/PFE · ARS

ARS 12,140

-189.88 (-1.5%)· Recorded snapshot

Market cap	258.3T
Revenue (ttm)	93.9T
Net income (ttm)	6.4T
EPS (ttm)	ARS 292
P/E (trailing)	41.5x
P/E (forward)	10.4x
Dividend	ARS 441 (3.63%)
Volume	17,498
Beta	0.28

Market data

Price

Recent price action with selectable time range.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-11-03
Employees	75,000
Employees change	-7,000
Employees growth	-7.95%
Enterprise value	ARS 338.4T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-28
First seen	2026-05-10
Fiscal year end	December
Founded	1849
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT111424
Last earnings date	2026-08-04
Last refreshed	2026-10-28
Last stock split date	2024-01-24
Last stock split type	Forward
Market cap	ARS 258.3T
Next earnings date	2026-11-03
Price	ARS 12,140.00
Price currency	ARS
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	bcba/PFE
Website	https://www.pfizer.com

Metric

Value

Amount currency

ARS

Country

United States

Country code

Earnings date

2026-11-03

Employees

75,000

Employees change

-7,000

Employees growth

-7.95%

Enterprise value

ARS 338.4T

Exchange

Buenos Aires Stock Exchange

Financial currency

USD

Financial report date

2026-06-28

First seen

2026-05-10

Fiscal year end

December

Founded

1849

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

ARDEUT111424

Last earnings date

2026-08-04

Last refreshed

2026-10-28

Last stock split date

2024-01-24

Last stock split type

Forward

Market cap

ARS 258.3T

Next earnings date

2026-11-03

Price

ARS 12,140.00

Price currency

ARS

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

bcba/PFE

Website

https://www.pfizer.com

Metric	Value
Average P/E ratio (10Y)	18.97x
Average P/E ratio (3Y)	26.74x
Average P/E ratio (5Y)	19.53x
Earnings yield	2.41%
EV/Earnings	53.43x
EV/EBIT	11.78x
EV/EBITDA	8.44x
EV/FCF	21.08x
EV/Sales	3.48x
FCF / EV yield	4.74%
FCF yield	6.2%
Forward P/E	10.42x
Graham number	6275.13524
Graham upside	-48.48%
Lynch fair value	ARS 1,489.30
Lynch upside	-87.77%
P/(FCF - SBC) ratio	17.66x
P/(OCF - SBC) ratio	14.23x
P/B ratio	2.07x
P/E ratio	41.54x
P/FCF ratio	16.13x
P/OCF ratio	13.22x
P/S ratio	2.78x
Price/EBITDA ratio	6.98x

Metric

Value

Average P/E ratio (10Y)

18.97x

Average P/E ratio (3Y)

26.74x

Average P/E ratio (5Y)

19.53x

Earnings yield

2.41%

EV/Earnings

53.43x

EV/EBIT

11.78x

EV/EBITDA

8.44x

EV/FCF

21.08x

EV/Sales

3.48x

FCF / EV yield

4.74%

FCF yield

6.2%

Forward P/E

10.42x

Graham number

6275.13524

Graham upside

-48.48%

Lynch fair value

ARS 1,489.30

Lynch upside

-87.77%

P/(FCF - SBC) ratio

17.66x

P/(OCF - SBC) ratio

14.23x

P/B ratio

2.07x

P/E ratio

41.54x

P/FCF ratio

16.13x

P/OCF ratio

13.22x

P/S ratio

2.78x

Price/EBITDA ratio

6.98x

Metric	Value
EBIT margin	29.58%
EBITDA margin	39.85%
FCF margin	16.53%
Gross margin	74.72%
Operating margin	29.58%
Pretax margin	6.61%
Profit margin	6.8%
Profit per employee	ARS 85.2M
Profitable years	41
Revenue per employee	ARS 1.3B
ROA	5.78%
ROA (5Y)	7.03%
ROCE	11.18%
ROE	5.01%
ROE (5Y)	17.68%
ROIC	13.49%
ROIC (5Y)	18.62%
SBC / revenue	1.49%
Tax / revenue	-0.26%

Metric

Value

EBIT margin

29.58%

EBITDA margin

39.85%

FCF margin

16.53%

Gross margin

74.72%

Operating margin

29.58%

Pretax margin

6.61%

Profit margin

6.8%

Profit per employee

ARS 85.2M

Profitable years

Revenue per employee

ARS 1.3B

ROA

5.78%

ROA (5Y)

7.03%

ROCE

11.18%

ROE

5.01%

ROE (5Y)

17.68%

ROIC

13.49%

ROIC (5Y)

18.62%

SBC / revenue

1.49%

Tax / revenue

-0.26%

Metric	Value
EPS growth	-59.88%
EPS growth 10Y	-3.88%
EPS growth 3Y	-41.3%
EPS growth 5Y	-19.56%
EPS growth years	0
FCF growth	-11.68%
FCF growth (QoQ)	-86.14%
FCF growth 3Y	0.99%
FCF growth 5Y	-12.27%
Gross profit growth	2.68%
Gross profit growth (Q)	2.04%
Gross profit growth 3Y	-4.76%
Gross profit growth 5Y	3.85%
Net income growth	-59.69%
Net income growth 3Y	-41.34%
Net income growth 5Y	-19.42%
Net income growth years	0
OCF growth	-11.77%
OCF growth (QoQ)	-68.07%
OCF growth 10Y	-1.34%
OCF growth 3Y	-2.73%
OCF growth 5Y	-10.66%
Operating income growth	11.09%
Operating income growth (Q)	-0.31%
Operating income growth 3Y	-10.2%
Operating income growth 5Y	5.06%
Revenue growth	-0.21%
Revenue growth (Q)	2.6%
Revenue growth (QoQ)	4.03%
Revenue growth 10Y	1.99%
Revenue growth 3Y	-6.7%
Revenue growth 5Y	2.93%
Revenue growth quarters	2
Revenue growth years	0

Metric

Value

EPS growth

-59.88%

EPS growth 10Y

-3.88%

EPS growth 3Y

-41.3%

EPS growth 5Y

-19.56%

EPS growth years

FCF growth

-11.68%

FCF growth (QoQ)

-86.14%

FCF growth 3Y

0.99%

FCF growth 5Y

-12.27%

Gross profit growth

2.68%

Gross profit growth (Q)

2.04%

Gross profit growth 3Y

-4.76%

Gross profit growth 5Y

3.85%

Net income growth

-59.69%

Net income growth 3Y

-41.34%

Net income growth 5Y

-19.42%

Net income growth years

OCF growth

-11.77%

OCF growth (QoQ)

-68.07%

OCF growth 10Y

-1.34%

OCF growth 3Y

-2.73%

OCF growth 5Y

-10.66%

Operating income growth

11.09%

Operating income growth (Q)

-0.31%

Operating income growth 3Y

-10.2%

Operating income growth 5Y

5.06%

Revenue growth

-0.21%

Revenue growth (Q)

2.6%

Revenue growth (QoQ)

4.03%

Revenue growth 10Y

1.99%

Revenue growth 3Y

-6.7%

Revenue growth 5Y

2.93%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	ARS -3.6T
Depreciation and amortization	ARS 10.1T
EBIT	ARS 27.8T
EBITDA	ARS 37.4T
EPS	ARS 292.22
Financing cash flow	ARS -12.4T
Free cash flow	ARS 16.2T
Free cash flow minus SBC	ARS 14.8T
Gross profit	ARS 70.2T
Income taxes	ARS -241.8B
Investing cash flow	ARS -8.4T
Net borrowing	ARS 2.7T
Net cash flow	ARS -973B
Net income	ARS 6.4T
Operating cash flow minus SBC	ARS 18.4T
Operating income	ARS 27.8T
Revenue	ARS 93.9T
Stock-based compensation	ARS 1.4T

Metric

Value

Capital expenditures

ARS -3.6T

Depreciation and amortization

ARS 10.1T

EBIT

ARS 27.8T

EBITDA

ARS 37.4T

EPS

ARS 292.22

Financing cash flow

ARS -12.4T

Free cash flow

ARS 16.2T

Free cash flow minus SBC

ARS 14.8T

Gross profit

ARS 70.2T

Income taxes

ARS -241.8B

Investing cash flow

ARS -8.4T

Net borrowing

ARS 2.7T

Net cash flow

ARS -973B

Net income

ARS 6.4T

Operating cash flow minus SBC

ARS 18.4T

Operating income

ARS 27.8T

Revenue

ARS 93.9T

Stock-based compensation

ARS 1.4T

Metric	Value
Altman Z-Score	2.22
Book value per share	ARS 22,036.69
Debt / EBITDA	2.41
Debt / equity	0.74
Debt / FCF	5.78
Goodwill	ARS 109.9T
Interest coverage	6.98
Long-term assets	ARS 232.9T
Long-term liabilities	ARS 120.3T
Net cash (debt)	ARS -76.3T
Net cash / market cap	-29.22%
Net debt / EBITDA	2.04
Net debt / equity	0.61
Net debt / FCF	4.71
Piotroski F-Score	7
Property, plant and equipment	ARS 29.3T
Shareholders' equity	ARS 126T
Tangible book value	ARS -49.1T
Tangible book value per share	ARS -8,609.29
Total assets	ARS 296.5T
Total cash	ARS 17.3T
Total debt	ARS 93.6T
Total liabilities	ARS 170.5T
WACC	5.13%

Metric

Value

Altman Z-Score

2.22

Book value per share

ARS 22,036.69

Debt / EBITDA

2.41

Debt / equity

0.74

Debt / FCF

5.78

Goodwill

ARS 109.9T

Interest coverage

6.98

Long-term assets

ARS 232.9T

Long-term liabilities

ARS 120.3T

Net cash (debt)

ARS -76.3T

Net cash / market cap

-29.22%

Net debt / EBITDA

2.04

Net debt / equity

0.61

Net debt / FCF

4.71

Piotroski F-Score

Property, plant and equipment

ARS 29.3T

Shareholders' equity

ARS 126T

Tangible book value

ARS -49.1T

Tangible book value per share

ARS -8,609.29

Total assets

ARS 296.5T

Total cash

ARS 17.3T

Total debt

ARS 93.6T

Total liabilities

ARS 170.5T

WACC

5.13%

Metric	Value
Asset turnover	0.31
Current assets	ARS 63.6T
Current liabilities	ARS 50.2T
Current ratio	1.27
Inventory turnover	1.49
Net working capital	ARS -418.7B
Quick ratio	0.85
Working capital	ARS 12.8T
Working capital turnover	12,785.16

Metric

Value

Asset turnover

0.31

Current assets

ARS 63.6T

Current liabilities

ARS 50.2T

Current ratio

1.27

Inventory turnover

1.49

Net working capital

ARS -418.7B

Quick ratio

0.85

Working capital

ARS 12.8T

Working capital turnover

12,785.16

Metric	Value
Buyback yield / dilution	-0.34%
Dividend growth	12.88%
Dividend growth (10Y)	5.49%
Dividend growth (3Y)	6.14%
Dividend growth (5Y)	5.62%
Dividend growth years	4
Dividend payment date	2026-12-07
Dividend payment years	27
Dividend payout frequency	Quarterly
Dividend per share	ARS 440.76
Dividend yield	3.63%
Ex-dividend date	2026-11-06
Last dividend	ARS 0.11
Payout ratio	225.77%
Shareholder yield	3.28%

Metric

Value

Buyback yield / dilution

-0.34%

Dividend growth

12.88%

Dividend growth (10Y)

5.49%

Dividend growth (3Y)

6.14%

Dividend growth (5Y)

5.62%

Dividend growth years

Dividend payment date

2026-12-07

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

ARS 440.76

Dividend yield

3.63%

Ex-dividend date

2026-11-06

Last dividend

ARS 0.11

Payout ratio

225.77%

Shareholder yield

3.28%

Metric	Value
10Y price change	9,912.38%
10Y return CAGR	62.65%
10Y total return	12,849.33%
150-day SMA	ARS 10,364.60
15Y price change	52,696.52%
15Y return CAGR	55.37%
15Y total return	74,148.27%
1D price change	-1.54%
1M price change	4.84%
1M total return	4.84%
1W price change	-1.22%
1W total return	-1.22%
1Y price change	34.33%
1Y return CAGR	40.06%
1Y total return	40.02%
20-day SMA	ARS 11,763.50
200-day SMA	ARS 10,239.65
20Y price change	57,320.12%
20Y return CAGR	40.79%
20Y total return	93,510.22%
3M price change	22.77%
3M total return	22.77%
3Y price change	84.53%
3Y return CAGR	27.07%
3Y total return	105.19%
50-day SMA	ARS 11,436.40
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 12,690.00
52-week high date	2026-10-26
52-week low	ARS 8,800.00
52-week low date	2025-11-10
5Y price change	459.57%
5Y return CAGR	44.79%
5Y total return	536.14%
6M price change	19.27%
6M total return	21.74%
All-time high	ARS 12,690.00
All-time high date	2026-10-26
All-time low	ARS 9.25
All-time low date	2001-09-19
Average true range (ATR)	ARS 260.75
Average volume	23.2K
Beta (5Y)	0.28
Change from 52-week high	-4.33%
Change from 52-week low	37.96%
Change from all-time high	-4.41%
Change from all-time low	131,035.14%
Change from open	-0.49%
Day's gap	-1.05%
Dollar volume	ARS 212.4M
High price	ARS 12,340.00
Low price	ARS 12,080.00
Monthly RSI	72.05
Open price	ARS 12,200.00
Position in 52-week range	23.08%
Previous close	ARS 12,330.00
Price vs 150-day SMA	17.03%
Price vs 20-day SMA	3.12%
Price vs 200-day SMA	18.46%
Price vs 50-day SMA	6.06%
Relative volume	0.75
RSI	60.83
Sharpe ratio	1.15
Sharpe ratio (3Y)	0.79
Sharpe ratio (5Y)	1.13
Sortino ratio	1.92
Sortino ratio (3Y)	1.34
Sortino ratio (5Y)	1.89
Volume	17.5K
Weekly RSI	69.46
YTD price change	27.89%
YTD total return	31.86%

Metric

Value

10Y price change

9,912.38%

10Y return CAGR

62.65%

10Y total return

12,849.33%

150-day SMA

ARS 10,364.60

15Y price change

52,696.52%

15Y return CAGR

55.37%

15Y total return

74,148.27%

1D price change

-1.54%

1M price change

4.84%

1M total return

4.84%

1W price change

-1.22%

1W total return

-1.22%

1Y price change

34.33%

1Y return CAGR

40.06%

1Y total return

40.02%

20-day SMA

ARS 11,763.50

200-day SMA

ARS 10,239.65

20Y price change

57,320.12%

20Y return CAGR

40.79%

20Y total return

93,510.22%

3M price change

22.77%

3M total return

22.77%

3Y price change

84.53%

3Y return CAGR

27.07%

3Y total return

105.19%

50-day SMA

ARS 11,436.40

50-day SMA vs 200-day SMA

50over200

52-week high

ARS 12,690.00

52-week high date

2026-10-26

52-week low

ARS 8,800.00

52-week low date

2025-11-10

5Y price change

459.57%

5Y return CAGR

44.79%

5Y total return

536.14%

6M price change

19.27%

6M total return

21.74%

All-time high

ARS 12,690.00

All-time high date

2026-10-26

All-time low

ARS 9.25

All-time low date

2001-09-19

Average true range (ATR)

ARS 260.75

Average volume

23.2K

Beta (5Y)

0.28

Change from 52-week high

-4.33%

Change from 52-week low

37.96%

Change from all-time high

-4.41%

Change from all-time low

131,035.14%

Change from open

-0.49%

Day's gap

-1.05%

Dollar volume

ARS 212.4M

High price

ARS 12,340.00

Low price

ARS 12,080.00

Monthly RSI

72.05

Open price

ARS 12,200.00

Position in 52-week range

23.08%

Previous close

ARS 12,330.00

Price vs 150-day SMA

17.03%

Price vs 20-day SMA

3.12%

Price vs 200-day SMA

18.46%

Price vs 50-day SMA

6.06%

Relative volume

0.75

RSI

60.83

Sharpe ratio

1.15

Sharpe ratio (3Y)

0.79

Sharpe ratio (5Y)

1.13

Sortino ratio

1.92

Sortino ratio (3Y)

1.34

Sortino ratio (5Y)

1.89

Volume

17.5K

Weekly RSI

69.46

YTD price change

27.89%

YTD total return

31.86%

Metric	Value
Float	5.7B
Shares change (QoQ)	-0.56%
Shares change (YoY)	0.34%
Shares held by insiders	0.03%
Shares held by institutions	68.07%
Short ratio	4 days

Metric

Value

Float

5.7B

Shares change (QoQ)

-0.56%

Shares change (YoY)

0.34%

Shares held by insiders

0.03%

Shares held by institutions

68.07%

Short ratio

4 days

BCBA/PFE (BCBA/PFE)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/PFE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/PFE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/PFE

Frequently asked questions